Yves Fradet - 9342-8530 Qubec Chairman
Chairman
Dr. Yves Fradet M.D. FRCS. serves as the Chairman of the Board President Chief Medical Officer of DiagnoCure Inc. He graduated from Medical School at Universit Laval in 1976 and is member of the Royal College of Physicians and Surgeons of Canada since 1981. He was full professor of surgeryurology at Universit Laval since 1992. He is also Director Urology Services and Director of the Experimental UroOncology Laboratory at the CHUQ HtelDieu de Qubec since 2010.
| Age | 72 |
| Tenure | 14 years |
| Professional Marks | Ph.D |
| Phone | 418-527-6100 |
| Web | http://www.diagnocure.com |
9342-8530 Qubec Management Efficiency
The company has return on total asset (ROA) of 1.3432 % which means that it generated a profit of $1.3432 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.2777 %, meaning that it generated $1.2777 on every $100 dollars invested by stockholders. 9342-8530 Qubec's management efficiency ratios could be used to measure how well 9342-8530 Qubec manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 6 records | CHAIRMAN Age | ||
| Guillermo Hinojosa | Tenaris SA ADR | 69 | |
| Hans Helmerich | Helmerich and Payne | 62 | |
| Paolo Rocca | Tenaris SA ADR | 71 | |
| Paul Rady | Antero Midstream Partners | 70 | |
| Lawrence Coben | NRG Energy | 65 | |
| Scott Helm | Vistra Energy Corp | 56 | |
Management Performance
| Return On Equity | 1.28 | |||
| Return On Asset | 1.34 |
9342 8530 Qubec Leadership Team
Elected by the shareholders, the 9342-8530 Qubec's board of directors comprises two types of representatives: 9342-8530 Qubec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 9342-8530. The board's role is to monitor 9342-8530 Qubec's management team and ensure that shareholders' interests are well served. 9342-8530 Qubec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, 9342-8530 Qubec's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yves Fradet, Non-Independent Chairman of the Board and Presidentident, Chief Medical Officer | ||
| Andrew Sheldon, Director | ||
| Pierre Dsy, Consulting Pres | ||
| Pierre Lapalme, Advisor Pres |
9342-8530 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is 9342-8530 Qubec a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.28 | |||
| Return On Asset | 1.34 | |||
| Profit Margin | 0.41 % | |||
| Operating Margin | 0.77 % | |||
| Current Valuation | (392.06 K) | |||
| Shares Outstanding | 43.04 M | |||
| Price To Sales | 0 X | |||
| Revenue | 515.37 K | |||
| Gross Profit | 117.96 K | |||
| EBITDA | 5.46 M |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in 9342-8530 Stock
If you are still planning to invest in 9342 8530 Qubec check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 9342-8530 Qubec's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |